These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6794637)

  • 1. Fractionation of individual, biologically active factor VIII multimers.
    Perret BA; Furlan M; Kneubuehl F; Beck EA
    Biochim Biophys Acta; 1981 Jun; 669(1):98-104. PubMed ID: 6794637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on factor VIII-related protein. II. Estimation of molecular size differences between factor VIII oligomers.
    Perret BA; Furlan M; Beck EA
    Biochim Biophys Acta; 1979 May; 578(1):164-74. PubMed ID: 454664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification of the factor VIII complex.
    Thorell L; Blombäck B
    Thromb Res; 1984 Aug; 35(4):431-50. PubMed ID: 6435279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Isolation and some properties of factor VIII (antihemophilic factor)].
    Bykowska K; Lopaciuk S; Michalski R
    Acta Haematol Pol; 1976 OCT-DEC; 7(4):283-92. PubMed ID: 998139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on factor VIII-related protein. I. Ultrastructural and electrophoretic heterogeneity of human factor VIII-related protein.
    Beck EA; Tranqui-Pouit L; Chapel A; Perret BA; Furlan M; Hudry-Clergeon G; Suscillon M
    Biochim Biophys Acta; 1979 May; 578(1):155-63. PubMed ID: 313218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variable degradation of factor VIII-related protein in lyophilised concentrates of antihaemophilic factor (AHF).
    Jakab T; Pflugshaupt R; Furlan M; Beck EA
    Vox Sang; 1978; 35(1-2):36-40. PubMed ID: 664567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and properties of bovine factor VIII (antihemophilic factor).
    Vehar GA; Davie EW
    Biochemistry; 1980 Feb; 19(3):401-10. PubMed ID: 7356933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on factor VIII-related protein. III. Size distribution and carbohydrate content of human and bovine factor VIII.
    Furlan M; Perret BA; Beck EA
    Biochim Biophys Acta; 1979 Aug; 579(2):325-33. PubMed ID: 534647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disulfide bonds and the quaternary structure of factor VIII/von Willebrand factor.
    Counts RB; Paskell SL; Elgee SK
    J Clin Invest; 1978 Sep; 62(3):702-9. PubMed ID: 308512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the human factor VIII procoagulant protein with a heterologous precipitating antibody.
    Fulcher CA; Zimmerman TS
    Proc Natl Acad Sci U S A; 1982 Mar; 79(5):1648-52. PubMed ID: 6803246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silver staining of high molecular weight proteins on large-pore polyacrylamide gels.
    Perret BA; Felix R; Furlan M; Beck EA
    Anal Biochem; 1983 May; 131(1):46-50. PubMed ID: 6193732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human factor VIII: purification from commercial factor VIII concentrate, characterization, identification and radiolabeling.
    Hamer RJ; Koedam JA; Beeser-Visser NH; Sixma JJ
    Biochim Biophys Acta; 1986 Oct; 873(3):356-66. PubMed ID: 3092864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parallel characterization of bovine von Willebrand protein (factor VIII-associated protein) by light scattering and SDS gel electrophoresis.
    Binnie C; Wagner RH; Cooper H; Hermans J
    Thromb Res; 1985 Nov; 40(4):523-32. PubMed ID: 3936230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two distinct forms of Factor VIII coagulant protein in human plasma. Cleavage by thrombin, and differences in coagulant activity and association with von Willebrand factor.
    Weinstein MJ; Chute LE
    J Clin Invest; 1984 Feb; 73(2):307-16. PubMed ID: 6421875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apparent molecular weight of purified human factor VIII procoagulant protein compared with purified and plasma factor VIII procoagulant protein antigen.
    Weinstein MJ; Fulcher CA; Chute LE; Zimmerman TS
    Blood; 1983 Nov; 62(5):1114-7. PubMed ID: 6414554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of storage of whole blood on the association of factor VIII-related antigen and factor VIII-coagulant antigen.
    Hellings JA; Over J; van Mourik JA
    Scand J Haematol; 1982 Nov; 29(5):353-62. PubMed ID: 6818685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on human antihemophilic factor. Evidence for a covalently linked subunit structure.
    Switzer ME; McKee PA
    J Clin Invest; 1976 Apr; 57(4):925-37. PubMed ID: 1084890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple molecular forms of endothelial cell factor VIII related antigen.
    Nachman RL; Jaffe EA; Ferris B
    Biochim Biophys Acta; 1981 Feb; 667(2):361-9. PubMed ID: 6783119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variant von Willebrand's disease: characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets.
    Ruggeri ZM; Zimmerman TS
    J Clin Invest; 1980 Jun; 65(6):1318-25. PubMed ID: 6773982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the nature of antihemophilic factor (factor VIII). Further evidence relating the AHF-like antigens in normal and hemophilic plasmas.
    Bennett B; Forman WB; Ratnoff OD
    J Clin Invest; 1973 Sep; 52(9):2191-7. PubMed ID: 4199413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.